Ansys Software’s HFSS solution has received the approval from Federal Communications Commission (FCC) standards that it can use specific electromagnetic applications in the healthcare industry.
The company’s HFSS software can now provide proof that a biomedical device transmitter design meets FCC standards, a ruling that will enable medical device developers to cut development time and costs while meeting safety standards.
The FCC ruled in February that the Finite Element Method (FEM) is a valid technique to simulate a medical device that must communicate with other similar devices. As a result, organizations in the medical equipment sector can use HFSS industry-leading FEM electromagnetic field simulation to validate their transmitter designs.
Now the FCC ruling allows researchers to innovate with HFSS, developing new approaches that they can get to market faster. Ansys requested that the FCC grant a waiver to the Medical Device Radio-communication Service rules to permit FEM environmental evaluation of medical implant or body-worn equipment. The ruling granting the waiver cited scientific literature stating that FEM is a sound engineering technique.
HFSS software, which incorporates industry-leading technology for 3-D full-wave electromagnetic field simulation, enables engineers to design, simulate and validate the behaviour of complex high-performance RF, microwave and millimeter-wave devices in next-generation wireless devices, defence communication systems, biomedical devices, and consumer electronics.
Today’s sophisticated medical implants and other equipment often contain transmitters that communicate with other devices, transferring physiological data to a doctor via wireless communication, for example, which can be used to monitor, diagnose or treat a patient’s condition. The new FCC ruling applies to transmitters that are placed inside, on, or in close proximity to the human body. Developers of such medical devices must ensure that their equipment meets Radio Frequency (RF) emission safety standards. Additionally, manufacturers must comply with Specific Absorption Rate (SAR) regulations, a measure of how the body absorbs energy when exposed to an RF electromagnetic field. HFSS software — which employs FEM simulation to verify both SAR and RF emissions — can also reduce development time and costs while increasing reliability and design optimization, according to the company.
“The HFSS finite element solution is extremely valuable for designing antenna systems for implantable devices,” said Mark Lanciault, principal electrical engineer, Cambridge Consultants Inc.
“Its use of an unstructured mesh is particularly well suited for modelling the complex curved surfaces within the human body, as seen in organs, tissues, and bones. Using HFSS allows us to optimize and verify performance of our implanted antenna designs in a representative environment. We will now be able to provide our customers accurate solutions specific to their device's location in the body,” he added.
“The medical device market is rapidly innovating to meet consumer demands and satisfy regulatory safety requirements,” said Markus Kopp, product manager for electronics, Ansys.